Cited 118 times in
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.